DOCSLIB.ORG

DSM Nutritional Products

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
DSM Nutritional Products SIGHT AND LIFE NEWSLETTER 1/2006 INCORPORATING THE XEROPHTHALMIA CLUB BULLETIN Correspondents: Bruno de Benoist, William S. Blaner, George Britton, Omar Dary, Frances R. Davidson, John W. Erdman, Jr., Tracey Goodman, Philip Harvey, Richard F. Hurrell, Rolf D. W. Klemm, Donald S. McLaren, Regina Moench-Pfanner, Christine Northrop-Clewes, Vin- odini Reddy, Delia Rodriguez-Amaya, Ram Kumar Shrestha, Noel W. Solomons, Florentino S. Solon, Alfred Sommer, Andrew Tomkins, G. Venkataswamy, Emorn Wasantwisut, Keith P. West Jr., Yu Xiaodong, Michael B. Zimmermann. Editor: Klaus Kraemer Lycopene function Community research in Bangladesh Micronutrient information at WHO IUNS Nutrition Congress Drawing contest Reader survey Annual report Ms Albertine Ramazani from the PROSEVITA project with a refugee family receiving help. Affected by war and social changes, refugee children are particularly vulnerable. They are among the ‘excluded and invisible’ addressed in UNICEF’s annual State of the World’s Children report (see page 47). SIGHT AND LIFE has been supporting Ms Ramazani‘s project for a long time (see article on page 23). SIGHT AND LIFE 2 NEWSLETTER 1/2006 Contents Lycopene intake and prostate cancer risk 4 Inauguration of the extension to the Red Cross Eye Hospital in Janakpur, Nepal; The JiVitA Bangladesh Project: Research to a successful investment against poverty- improve nutrition and health among mothers induced blindness 28 and infants in rural South Asia 10 Edible oil fortification in Bangladesh 29 The micronutrient deficiency information system at the World Health Organization 15 Rural and urban Targeted Initiative Programs in Calcutta 31 Low-income South African consumers’ under- standing of vitamins and minerals and Going Yellow video promotes healthy food fortification 17 food in Micronesia 31 18th International Congress of Nutrition held A digest of recent literature 34 in Durban, South Africa 19 Letters to the editor 42 A campaign to raise awareness of and Publications 44 combat vitamin A deficiency 23 Drawing contest on nutrition for health 48 Vision screening and vitamin A distribution in Achina and Owerre Akokwa, Nigeria 25 SIGHT AND LIFE Annual Report 2005 49 Questionnaire survey of our readers 55 A mother and child health care project in Endaselassie, Ethiopia 26 SIGHT AND LIFE, back cover SIGHT AND LIFE is a humanitarian initiative of DSM Nutritional Products DSM Nutritional Products DSM Nutritional Products is the world‘s leading supplier of vitamins, carotenoids and other fine chemicals to the feed, food, pharmaceutical and personal care industries. The company has a long tradition as a pioneer in the discovery of new products, new formulations and attractive applications for all industry segments. For further company information please visit www.dsmnutritionalproducts.com DSM DSM is active in nutritional and pharma ingredients, performance materials and industrial chemicals. The company creates innovative products and services that help improve the quality of life. DSM’s products are used in a wide range of end markets and applications such as human and animal nutrition and health, cosmetics, pharmaceuticals, automotive and transport, coatings, housing and electrics & electronics (E&E). DSM’s strategy, named Vision 2010 – Building on Strengths, focuses on accelerating profitable and innovative growth of the company’s specialties portfolio. Market-driven growth, innovation and increased presence in emerging economies are key drivers of this strategy. The group has annual sales of over € 8 billion and employs some 22,000 people worldwide. DSM ranks among the global leaders in many of its fields. The company is headquartered in the Netherlands, with locations in Europe, Asia, Africa and the Americas. NEWSLETTER 1/2006 3 SIGHT AND LIFE Editorial Micronutrient deficiencies are will gain momentum during 2006, largely responsible for maternal as the World Bank has given and infant mortality in developing malnutrition top priority in a new countries. Population-based ap- report ‘Repositioning Nutrition as proaches to control deficiencies Central to Development’. Malnu- in vitamin A, iron, folate and other trition has been known for a long micronutrients do, however, need time to increase poverty, and the to be based on scientific evidence. fight against malnutrition is crucial One example of a high-quality for economic growth. The World community research program is Bank cautions that malnutrition the JiVitA Bangladesh Project in poor countries may cost them (page 10). In January, I had an up to 3% of their yearly GDP and opportunity to join Alfred Sommer, mean children losing more than Keith West, Parul Christian and 10% of their lifetime income po- Alain Labrique of the Johns Hop- tential. “Put nutrition at the center kins Bloomberg School of Public of development so that a wide Health on a trip to ‘JiVitA-land’ in range of economic and social The time for talking Bangladesh, and to see for myself improvements that depend on nu- should be over a very dedicated local team doing trition can be realized”, the report outstanding research. says. The report also tells us that The year 2005 was a year of big malnutrition has its most damag- speeches by the world’s leaders Undernutrition and micronutrient ing effect between conception in the fight against poverty in the deficiencies are still prevalent in and the first two years in the life developing world, so it follows that developing countries, even as of a child. During this early period 2006 should be a year of action. Western-type food habits and malnutrition causes irreversible By coincidence, this year we are sedentary lifestyles are increas- damage to health and brain devel- celebrating the 20th anniversary ingly being adopted. This leads to opment, increasing school failure of SIGHT AND LIFE, and action overweight and chronic diseases. and reducing work performance. is exactly what we expect of our- Micronesia is a typical example of Moreover, at this early stage in life selves, within the realms of our this dual burden. The increasing malnutrition programs the risk for possibilities. We will align our problems with overweight and obesity and the chronic diseases activities to our new vision (to diabetes and the concomitant vi- of adulthood. The report also combat all types of micronutrient tamin A deficiency are featured in suggests solutions for tackling deficiencies), and we aim to serve a humorous film from Micronesia malnutrition and highlights that your needs even better than be- ‘Going Yellow’, communicated by many developing countries have fore. To this end we are seeking Lois Englberger in this edition of made impressive progress in your feedback on SIGHT AND the Newsletter (page 31). spite of economic setbacks and LIFE. This edition of the Newslet- poor governance. ter contains a questionnaire which The contribution by Jane Badham we kindly ask you to fill in and re- (page 17) on South African con- Is there hope that the time for turn to us. Furthermore, we shall sumers’ knowledge of vitamins talking is over and that action will in future be focusing on health and minerals and food fortification follow? As far as SIGHT AND issues rather than on specific highlights what we often neglect: LIFE is concerned, I am confident vitamin or mineral deficiencies. well-designed communication that we are on the right track. But One of the most important health strategies. Communication also besides sound science and eco- issues is anemia, which affects brings me to the SIGHT AND LIFE nomic incentives this will require more that 2 billion people world- Drawing Contest for children to good communication strategies wide. A SIGHT AND LIFE manual increase awareness of Nutrition to make programs really suc- on ‘Nutritional Anemia’, address- for Health (page 48). Children do cessful. ing contributing factors other than have excellent communication iron, is in preparation. Top experts skills and get down to the nitty- from different fields have agreed gritty immediately. Please help us to contribute chapters. You will to make the contest a success by find these and other examples of advertising the competition. our planned activities for 2006, as well as the Annual Report 2005, There is good reason to think that on page 49 of the Newsletter. the fight against hidden hunger SIGHT AND LIFE 4 NEWSLETTER 1/2006 Lycopene intake and prostate cancer risk Nikki A Ford and John W Erdman Jr., Division of Nutritional Sciences, University of Illinois, Urbana Champaign Introduction The red pigment lycopene, the most abundant carotenoid in tomatoes, is also found in lesser amounts in guava, pink grapefruit, papaya, and watermelon. Upon consumption, it accumulates in tissues including liver, adrenals, testes, and prostate (1). Lycopene is a 40 carbon atom, acyclic, open chain polyisoprenoid with 11 conjugated double bonds (2). All-trans lycopene is the predomi- nant isomer found in plants, but cis isomers are the form most The dominating red pigment of tomatoes is lycopene. At a vegetable market commonly found in human tissues in Bangladesh. suggesting preferential absorp- tion of cis isomers (3). of prostate cancer. This paper will Tomatoes also contain a variety review the composition of toma- of carotenoids in addition to lyco- Nearly all men will develop some toes and the epidemiological and pene. While lycopene comprises form of prostate cancer if they experimental evidence regarding approximately 60–64% of the live long enough (4). With a 32% the association between lyco- total carotenoids found in tomato mortality rate, prostate cancer is pene and tomato consumption products, phytoene, phytofluene, the second most abundant cancer and prostate cancer risk. Finally, neurosporene and γ-carotene are world-wide (5). North America potential mechanisms of action the next most abundant caroten- and Australia, along with parts and metabolites and oxidative oids (Figure 2). of South America and Europe, products of lycopene will be dis- have the highest incidence rates cussed. One in vitro study suggests that of prostate cancer (Table 1). Its lycopene works synergistically with occurrence is also high in parts of Tomato composition other tomato components to exert Africa, and Central America.
Load more

Recommended publications
  • Forgotten F1 Teams – Series 1 Omnibus Simtek Grand Prix
    Forgotten F1 Teams – Series 1 Omnibus Welcome to Forgotten F1 Teams – a mini series from Sidepodcast. These shows were originally released over seven consecutive days But are now gathered together in this omniBus edition. Simtek Grand Prix You’re listening to Sidepodcast, and this is the latest mini‐series: Forgotten F1 Teams. I think it’s proBaBly self explanatory But this is a series dedicated to profiling some of the forgotten teams. Forget aBout your Ferrari’s and your McLaren’s, what aBout those who didn’t make such an impact on the sport, But still have a story to tell? Those are the ones you’ll hear today. Thanks should go to Scott Woodwiss for suggesting the topic, and the teams, and we’ll dive right in with Simtek Grand Prix. Simtek Grand Prix was Born from Simtek Research Ltd, the name standing for Simulation Technology. The company founders were Nick Wirth and Max Mosley, Both of whom had serious pedigree within motorsport. Mosley had Been a team owner Before with March, and Wirth was a mechanical engineering student who was snapped up By March as an aerodynamicist, working underneath Adrian Newey. When March was sold to Leyton House, Mosley and Wirth? Both decided to leave, and joined forces to create Simtek. Originally, the company had a single office in Wirth’s house, But it was soon oBvious they needed a Bigger, more wind‐tunnel shaped Base, which they Built in Oxfordshire. Mosley had the connections that meant racing teams from all over the gloBe were interested in using their research technologies, But while keeping the clients satisfied, Simtek Began designing an F1 car for BMW in secret.
    [Show full text]
  • Biosynthesis of Abscisic Acid by the Direct Pathway Via Ionylideneethane in a Fungus, Cercospora Cruenta
    Biosci. Biotechnol. Biochem., 68 (12), 2571–2580, 2004 Biosynthesis of Abscisic Acid by the Direct Pathway via Ionylideneethane in a Fungus, Cercospora cruenta y Masahiro INOMATA,1 Nobuhiro HIRAI,2; Ryuji YOSHIDA,3 and Hajime OHIGASHI1 1Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto 606-8502, Japan 2International Innovation Center, Kyoto University, Kyoto 606-8501, Japan 3Department of Agriculture Technology, Toyama Prefectural University, Toyama 939-0311, Japan Received August 11, 2004; Accepted September 12, 2004 We examined the biosynthetic pathway of abscisic Key words: Cercospora cruenta; abscisic acid; allofar- acid (ABA) after isopentenyl diphosphate in a fungus, nesene; -ionylideneethane; all-E-7,8-dihy- Cercospora cruenta. All oxygen atoms at C-1, -1, -10, and dro- -carotene -40 of ABA produced by this fungus were labeled with 18 18 O from O2. The fungus did not produce the 9Z- A sesquiterpenoid, abscisic acid (ABA, 1), is a plant carotenoid possessing -ring that is likely a precursor hormone which regulates seed dormancy and induces for the carotenoid pathway, but produced new sesqui- dehydration tolerance by reducing the stomatal aper- terpenoids, 2E,4E- -ionylideneethane and 2Z,4E- -ion- ture.1) ABA is biosynthesized by some phytopathogenic ylideneethane, along with 2E,4E,6E-allofarnesene. The fungi in addition to plants,2) but the biosynthetic origin fungus converted these sesquiterpenoids labeled with of isopentenyl diphosphate (IDP) for fungal ABA is 13C to ABA, and the incorporation ratio of 2Z,4E- - different from that for plant ABA (Fig. 1). Fungi use ionylideneethane was higher than that of 2E,4E- - IDP derived from the mevalonate pathway for ABA, ionylideneethane.
    [Show full text]
  • Bioactive Compounds of Tomatoes As Health Promoters
    48 Natural Bioactive Compounds from Fruits and Vegetables, 2016, Ed. 2, 48-91 CHAPTER 3 Bioactive Compounds of Tomatoes as Health Promoters José Pinela1,2, M. Beatriz P. P Oliveira2, Isabel C.F.R. Ferreira1,* 1 Mountain Research Centre (CIMO), ESA, Polytechnic Institute of Bragança, Campus de Santa Apolónia, Ap. 1172, 5301-855 Bragança, Portugal 2 REQUIMTE/LAQV, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal Abstract: Tomato (Lycopersicon esculentum Mill.) is one of the most consumed vegetables in the world and probably the most preferred garden crop. It is a key component of the Mediterranean diet, commonly associated with a reduced risk of chronic degenerative diseases. Currently there are a large number of tomato cultivars with different morphological and sensorial characteristics and tomato-based products, being major sources of nourishment for the world’s population. Its consumption brings health benefits, linked with its high levels of bioactive ingredients. The main compounds are carotenoids such as β-carotene, a precursor of vitamin A, and mostly lycopene, which is responsible for the red colour, vitamins in particular ascorbic acid and tocopherols, phenolic compounds including hydroxycinnamic acid derivatives and flavonoids, and lectins. The content of these compounds is variety dependent. Besides, unlike unripe tomatoes, which contain a high content of tomatine (glycoalkaloid) but no lycopene, ripe red tomatoes contain high amounts of lycopene and a lower quantity of glycoalkaloids. Current studies demonstrate the several benefits of these bioactive compounds, either isolated or in combined extracts, namely anticarcinogenic, cardioprotective and hepatoprotective effects among other health benefits, mainly due to its antioxidant and anti-inflammatory properties.
    [Show full text]
  • FINAL -SIRS-Program-Book-2018-Online.Pdf
    6th Schizophrenia International Research Society Conference Integrated Prevention and Treatment: Shifting the Way We Think FLORENCE, ITALY 4 – 8 APRIL 2018 6th Schizophrenia International Research Society Conference Integrated Prevention and Treatment: Shifting the Way We Think Opening Letter Dear Attendees, It is our great pleasure to welcome you to the 6th Biennial Schizophrenia International Research Society (SIRS) Conference. SIRS is a non-profit organization dedicated to promoting research and communication about schizophrenia among research scientists, clinicians, drug developers, and policy makers internationally. We sincerely appreciate your interest in the Society and in our conference. The fifth congress in 2016 was a major success for the field attracting more than 1800 attendees from 52 countries. We anticipate an even higher attendance at this congress with most of the best investigators in the world in attendance. SIRS was founded in 2005 with the goal of bringing together scientists from around the world to exchange the latest advances in biological and psychosocial research in schizophrenia. The Society is dedicated to facilitating international collaboration to discover the causes of, and better treatments for, schizophrenia and related disorders. Part of the mission of the Society is to promote educational programs in order to effectively disseminate new research findings and to expedite the publication of new research on schizophrenia. The focus of the 6th Biennial Conference is ‘Integrated Prevention and Treatment: Shifting the Way We Think’. Under the outstanding leadership of Program Committee Chairs, Paola Dazzan, Bita Moghaddam, and Eóin Killackey, we have an exciting scientific program planned for this year. The Program Committee selected thirty-five outstanding symposia sessions out of 103 submissions.
    [Show full text]
  • Curriculum Vitae
    CV – Alfred Sommer, MD, MHS 1 November 4, 2009 CURRICULUM VITAE NAME: ALFRED SOMMER, MD, MHS CITIZENSHIP: American BORN: October 2, 1942, New York, New York MARRIED: Jill Sommer CHILDREN: Charles Andrew Sommer Marni Jane Sommer PRESENT Dean Emeritus Professor, Epidemiology and International Health Johns Hopkins Bloomberg School of Public Health 615 N. Wolfe Street, Room E6527 Baltimore, MD 21205 Telephone: 410-502-4167 Facsimile: 410-502-4169 [email protected] Professor, Ophthalmology, Wilmer Institute Johns Hopkins University School of Medicine PAST Dean, Johns Hopkins Bloomberg School of Public Health, 1990-2005 EDUCATION: MHS, Epidemiology, Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland, 1973 MD, Harvard Medical School, Boston, Massachusetts, 1967 BS, Summa Cum Laude, Union College, Schenectady, New York, 1963 PROFESSIONAL TRAINING: Resident and Fellow in Ophthalmology, Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore, Maryland, 1973-76 Fellow in Epidemiology, Johns Hopkins School of Hygiene & Public Health, Baltimore, Maryland, 1972-73 Medical Intern and Resident, Beth Israel Hospital, Harvard University, Boston, Massachusetts, 1967-69 CERTIFICATION: Diplomate, American Board of Ophthalmology, 1977 Diplomate, National Board of Medical Examiners, 1968 CV – Alfred Sommer, MD, MHS 2 HONORS: National Academy of Sciences, elected 2001 Institute of Medicine, elected 1992 Gonin Medal, International Council of Ophthalmology (and the Swiss Ophthalmological Association), 2006 Pollin Prize in Pediatric Research (Columbia University), 2004 Lucien Howe Medal, American Ophthalmological Society, 2003 Warren Alpert Research Prize (Harvard Medical School), 2003 International Duke Elder Gold Medal, International Council of Ophthalmology, 1998 Albert Lasker Clinical Medical Research Award, 1997 Helmut Horten Medical Research Award, Helmut Horten Stiftung, Switzerland, 1997 Prince Mahidol Award for International Contributions to Medicine and Public Health, Thailand, 1997 Charles A.
    [Show full text]
  • 2004 World Food Prize International Symposium from Asia to Africa: Rice, Biofortification, and Enhanced Nutrition October 14-15 - Des Moines, Iowa ______
    2004 World Food Prize International Symposium From Asia to Africa: Rice, Biofortification, and Enhanced Nutrition October 14-15 - Des Moines, Iowa ______________________________________________________________________________ October 14, 2004 – 3:00 p.m. HIDDEN HUNGER: THE ROLE OF NUTRITION, FORTIFICATION, AND BIOFORTIFICATION Dr. Alfred Sommer Dean Johns Hopkins Bloomberg School of Public Health Good afternoon. I’m delighted to be here and given the opportunity to address this august audience. I’m going to talk a little bit differently than most of the other people have, from a clinical and a health perspective. So we’ve heard something about the role of the Rockefeller Foundation in moving forward an important agricultural agenda over the recent past. There’s also been reference made that the traditional area of interest of the Rockefeller Foundation had been in public health. And indeed the institution where I am Dean, Johns Hopkins School of Public Health, was the first school of public health founded in this country, and it was founded with support of the Rockefeller Foundation. One of the first faculty members recruited to the school was this gentleman, E.V. McCullen, who we stole away from Wisconsin where he did work on an agricultural research station. He became the first professor and chair of biochemistry at the Hopkins School of Public Health. And as many of you probably know, he is the person who first described vitamin A. This is their paper from 1913. So what goes around comes around. E.V. McCullen’s portrait hangs in our board room. Now, one of the most important early observations of the classical deficiency, the one in which most public health and clinical research is focused, up until about two decades ago, was on the very striking ocular manifestations of the deficiency.
    [Show full text]
  • Read Our 2020-2021 Annual Report
    2020-2021 ANNUAL REPORT TABLE OF CONTENTS LETTER FROM THE CENTER DIRECTOR ABOUT THE CENTER 3 As we eventually achieve some distance from 2020 much will be said about the extraordinary year. STRATEGIC VISION 7 Yet despite the unprecedented upheaval caused by the global COVID-19 pandemic, the TIMELINE 18 2020-21 academic year feels like the year the Johns Hopkins Cochlear Center for Hearing and Public Health really hit its stride. Our training and mentoring opportunities are NEW VENTURES 22 sought-after, and we have had exceptional cohorts of trainees. Our large epidemiological studies and clinical trials continue, with one randomized trial testing the efficacy of a RESEARCH 26 community health worker model of hearing care delivery completed this past year. And we TRAINING 32 are optimistic that this year the Food and Drug Administration will finalize their regulatory classification for over-the-counter hearing aids which were due to be released in August EVENTS 41 2020 but delayed due to the COVID-19 pandemic. FACULTY & STAFF 44 Some things remain necessarily paused: The Longitudinal Aging Study in India (LASI), National Health and Aging Trends Study (NHATS), and other large epidemiological studies where NEWS & MEDIA 57 we’ve led the addition of hearing assessments are on hold until face-to-face interactions with research participants can be restarted safely. Other studies including the ACHIEVE trial, ARIC PRESENTATIONS & PUBLICATIONS 64 study, and a study of inpatient hearing care provision at Johns Hopkins are just now resuming in-person study visits after being on pause for the past year. Some things we expanded or improved: We developed an online format for our Fellows Program in Aging, Hearing, and Public Health which is designed for overseas clinicians and researchers, and in June 2021 we will debut this program with the Latin American fellows who were accepted to last summer’s in-person program which had to be cancelled.
    [Show full text]
  • Stock List Updated 28/09/2021
    1:43 Formula 1 - Stock List Updated 28/09/2021 Limited Price Model Year Description Manufacturer Manuf # Edition (AUD) F o r m u l a 1 , 2 a n d 3 Alfa Romeo 158 1950 Race car (25) (Oro Series) Brumm R036 35.00 Alfa Romeo 158 1950 L.Fagioli (12) 2nd Swiss GP Brumm S055 5000 40.00 Alfa Romeo 159 1951 Consalvo Sanesi (3) 6th British GP Minichamps 400511203 55.00 Alfa Romeo Ferrari C38 2019 K.Raikkonen (7) Bahrain GP Minichamps 447190007 222 135.00 Alfa Romeo Ferrari C39 2020 K.Raikkonen (7) Turkish GP Spark S6492 100.00 Alpha Tauri Honda AT01 2020 D.Kvyat (26) Austrian GP Minichamps 417200126 400 125.00 Alpha Tauri Honda AT01 2020 P.Gasly (10) 1st Italian GP Spark S6480 105.00 Alpha Tauri Honda AT01 2020 P.Gasly (10) 7th Austrian GP Spark S6468 100.00 Andrea Moda Judd S921 1992 P.McCathy (35) DNPQ Monaco GP Spark S3899 100.00 Arrows BMW A8 1986 M.Surer (17) Belgium GP "USF&G" Last F1 race Minichamps 400860017 75.00 Arrows Mugen FA13 1992 A.Suzuki (10) "Footwork" Onyx 146 25.00 Arrows Hart FA17 1996 R. Rosset (16) European GP Onyx 284 30.00 Arrows A20 1999 T.Takagi (15) show car Minichamps 430990084 25.00 Australian GP Event car 2001 Qantas AGP Event car Minichamps AC4010300 3000 40.00 Auto Union Tipo C 1936 R.Gemellate (6) Brumm R110 38.00 BAR Supertec 01 2000 J.Villeneuve test car Minichamps 430990120 40.00 BAR Honda 03 2001 J.Villeneuve (10) Minichamps 400010010 35.00 BAR Honda 005 2003 T.Sato collection (16) Japan GP standing driver Minichamps 518034316 35.00 BAR Honda 006 2004 J.
    [Show full text]
  • Multiplicity of Carotene Patterns Derives from Competition Between
    www.nature.com/scientificreports OPEN Multiplicity of carotene patterns derives from competition between phytoene desaturase diversifcation and biological environments Mathieu Fournié1,2,3 & Gilles Truan1* Phytoene desaturases catalyse from two to six desaturation reactions on phytoene, generating a large diversity of molecules that can then be cyclised and produce, depending on the organism, many diferent carotenoids. We constructed a phylogenetic tree of a subset of phytoene desaturases from the CrtI family for which functional data was available. We expressed in a bacterial system eight codon optimized CrtI enzymes from diferent clades. Analysis of the phytoene desaturation reactions on crude extracts showed that three CrtI enzymes can catalyse up to six desaturations, forming tetradehydrolycopene. Kinetic data generated using a subset of fve purifed enzymes demonstrate the existence of characteristic patterns of desaturated molecules associated with various CrtI clades. The kinetic data was also analysed using a classical Michaelis–Menten kinetic model, showing that variations in the reaction rates and binding constants could explain the various carotene patterns observed. Competition between lycopene cyclase and the phytoene desaturases modifed the distribution between carotene intermediates when expressed in yeast in the context of the full β-carotene production pathway. Our results demonstrate that the desaturation patterns of carotene molecules in various biological environments cannot be fully inferred from phytoene desaturases classifcation but is governed both by evolutionary-linked variations in the desaturation rates and competition between desaturation and cyclisation steps. Carotenoids are organic pigments produced by plants, algae, fungi, and bacteria and can be subdivided into two families of molecules, carotenes and their oxidised counterparts, xanthophylls 1.
    [Show full text]
  • Conversation Between Alfred Sommer, MD MHS and Daniel M. Albert, MD Chicago IL, October 15, 2010
    The Foundation of the American Academy of Ophthalmology Museum of Vision & Ophthalmic Heritage Conversation Between Alfred Sommer, MD MHS and Daniel M. Albert, MD Chicago IL, October 15, 2010 Drs. Al Sommer and Dan Albert recorded this conversation on October 15, 2010 during the Annual Meeting of the American Academy of Ophthalmology, in Chicago, IL. Dr. Sommer is a glaucoma specialist from Baltimore and Dr. Albert is an ophthalmic pathologist living in Madison. You are invited now to listen to excerpts and read the complete transcript below. Here, Dr. Albert discusses why he chose to study both pathology and ophthalmology. In this excerpt, Dr. Sommer describes how he became involved with epidemiology and public health. The Foundation of the American Academy of Ophthalmology Museum of Vision & Ophthalmic Heritage Conversation Between Alfred Sommer, MD MHS and Daniel M. Albert, MD Chicago IL, October 15, 2010 ALFRED SOMMER: I’m Al Sommer, and I am 68, and I am speaking with Dan Albert. DANIEL ALBERT: I’m Dan Albert, I’m 73, and I have the pleasure of speaking with Al Sommer. AL: So, Dan, should we start off with our roots? DAN: Okay. AL: So you grew up on the other side of the river from where I was born… DAN: Right. AL: I was born in Brooklyn and you were born in…? DAN: Newark, New Jersey. AL: Did you go to public schools there or… DAN: Yes, I did. And yourself? AL: Yes, same thing. They had good public schools in those days. I went to public schools in Brooklyn and then just my last two years of high school in Queens.
    [Show full text]
  • Free Radicals in Biology and Medicine Page 0
    77:222 Spring 2005 Free Radicals in Biology and Medicine Page 0 This student paper was written as an assignment in the graduate course Free Radicals in Biology and Medicine (77:222, Spring 2005) offered by the Free Radical and Radiation Biology Program B-180 Med Labs The University of Iowa Iowa City, IA 52242-1181 Spring 2005 Term Instructors: GARRY R. BUETTNER, Ph.D. LARRY W. OBERLEY, Ph.D. with guest lectures from: Drs. Freya Q . Schafer, Douglas R. Spitz, and Frederick E. Domann The Fine Print: Because this is a paper written by a beginning student as an assignment, there are no guarantees that everything is absolutely correct and accurate. In view of the possibility of human error or changes in our knowledge due to continued research, neither the author nor The University of Iowa nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from the use of such information. Readers are encouraged to confirm the information contained herein with other sources. All material contained in this paper is copyright of the author, or the owner of the source that the material was taken from. This work is not intended as a threat to the ownership of said copyrights. S. Jetawattana Lycopene, a powerful antioxidant 1 Lycopene, a powerful antioxidant by Suwimol Jetawattana Department of Radiation Oncology Free Radical and Radiation Biology The University
    [Show full text]
  • Transcriptional Analysis of Carotenoids Accumulation and Metabolism in a Pink-Fleshed Lemon Mutant
    G C A T T A C G G C A T genes Article Transcriptional Analysis of Carotenoids Accumulation and Metabolism in a Pink-Fleshed Lemon Mutant Giuseppe Lana 1 , Jaime Zacarias-Garcia 2 , Gaetano Distefano 1 , Alessandra Gentile 1, María J. Rodrigo 2 and Lorenzo Zacarias 2,* 1 Department of Agriculture, Food and Environment, University of Catania, 95123 Catania, Italy; [email protected] (G.L.); [email protected] (G.D.); [email protected] (A.G.) 2 Food Biotechnology Department, Instituto de Agroquímica y Tecnología de Alimentos, Consejo Superior de Investigaciones Científicas (IATA-CSIC), Paterna, 46980 Valencia, Spain; [email protected] (J.Z.-G.); [email protected] (M.J.R.) * Correspondence: [email protected]; Tel.: +34-963-900-022; Fax: +34-963-636-301 Received: 8 September 2020; Accepted: 28 October 2020; Published: 30 October 2020 Abstract: Pink lemon is a spontaneous bud mutation of lemon (Citrus limon, L. Burm. f) characterized by the production of pink-fleshed fruits due to an unusual accumulation of lycopene. To elucidate the genetic determinism of the altered pigmentation, comparative carotenoid profiling and transcriptional analysis of both the genes involved in carotenoid precursors and metabolism, and the proteins related to carotenoid-sequestering structures were performed in pink-fleshed lemon and its wild-type. The carotenoid profile of pink lemon pulp is characterized by an increased accumulation of linear carotenoids, such as lycopene, phytoene and phytofluene, from the early stages of development, reaching their maximum in mature green fruits. The distinctive phenotype of pink lemon is associated with an up-regulation and down-regulation of the genes upstream and downstream the lycopene cyclase, respectively.
    [Show full text]